ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Bushes Restate Commitment to Dialogue

August 8, 2003

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001